{"brief_title": "Buprenorphine Dosing Interval - 5", "brief_summary": "The purpose of this study is to explore the feasibility of extending the dosing interval of well maintained buprenorphine patients to 48 and 72 hours, leading to eventual 3 times/week dosing.", "condition": ["Opioid-Related Disorders"], "intervention_type": ["Drug"], "intervention_name": ["Buprenorphine"], "criteria": "Inclusion Criteria: M/F ages 21-50. Opiate dependence according to DSM-IV critera. Self-reported use within the last 30 days. Agreeable to conditions of study and signed informed consent. Exclusion Criteria: Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative-hynotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.", "gender": "All", "minimum_age": "21 Years", "maximum_age": "50 Years", "healthy_volunteers": "No", "mesh_term": ["Opioid-Related Disorders", "Buprenorphine"], "id": "NCT00000209"}